- The trend backdrop is active with a 23-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
ALEMG
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Laboratoires Euromedis Société anonyme · Healthcare · Medical Distribution
Latest close
5.20 EUR
4.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.2% above the Trend Line and sits at 59.6% of its 52-week range. The latest completed week returned 4.0%, after a 6.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
50
out of 100
Latest Close
5.20 EUR
7 Aug 2026
1W Return
4.0%
latest completed week
4W Return
6.6%
short-term follow-through
12W Return
4.0%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
0.2x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 36.78% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.0%
Latest completed week; four-week move 6.6%.
Indicator stack
77/18
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.78%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.2% above the Trend Line and sits at 59.6% of its 52-week range. The latest completed week returned 4.0%, after a 6.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6512-week average 0.75
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.6% over four weeks, 4.0% over 12 weeks, and 18.7% over one year. The current trend has remained active for 23 consecutive weeks.
Performance by holding period
Active trend streak23 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.49Latest activity-pressure read.
Pressure change-289.5%Four-week change in activity pressure.
Leadership9.35Latest relative-leadership reading.
RS change20.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.4%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2613 weeks finished lower.
Best week+14.1%Week of 10 Apr.
Worst week-6.9%Week of 3 Apr.
Latest week+4.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains3
Flat weeks2
Modest losses10
Sharp losses3
Recent vol4.2%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split23/24Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank13 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Distribution
4-week rank1 / 2
Group average2.0%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD0.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis75/100Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.
Activity pressure 0.65; No reversal markers Next-Week ExpectancyNegative 36.78%Next-week expectancy is negative with a 36.78% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Laboratoires Euromedis Revenue Breakdown – EURONEXT:ALEMG Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 5.20 EUR | 4.0% | 4.76 EUR | 4.57 EUR | -0.49 | 9.35 | 3.7K | On |
| 31 Jul 2026 | 5.00 EUR | 0.8% | 4.72 EUR | 4.57 EUR | -0.61 | 7.80 | 15.4K | On |
| 24 Jul 2026 | 4.96 EUR | -3.7% | 4.69 EUR | 4.58 EUR | -0.52 | 8.72 | 4.1K | On |
| 17 Jul 2026 | 5.15 EUR | 5.5% | 4.65 EUR | 4.58 EUR | -0.25 | 13.48 | 3.2K | On |
| 10 Jul 2026 | 4.88 EUR | -2.4% | 4.61 EUR | 4.58 EUR | -0.13 | 7.75 | 2.1K | On |
| 3 Jul 2026 | 5.00 EUR | -4.8% | 4.58 EUR | 4.58 EUR | -0.03 | 8.27 | 0 | On |
| 26 Jun 2026 | 5.25 EUR | 2.9% | 4.54 EUR | 4.57 EUR | 0.20 | 15.35 | 4 | On |
| 19 Jun 2026 | 5.10 EUR | 4.1% | 4.50 EUR | 4.57 EUR | 0.31 | 11.82 | 320 | On |
| 12 Jun 2026 | 4.90 EUR | -4.9% | 4.46 EUR | 4.57 EUR | 0.48 | 8.53 | 517 | On |
| 5 Jun 2026 | 5.15 EUR | -2.8% | 4.43 EUR | 4.56 EUR | 0.84 | 16.10 | 1.6K | On |
| 29 May 2026 | 5.30 EUR | 9.1% | 4.38 EUR | 4.56 EUR | 1.01 | 20.62 | 6.3K | On |
| 22 May 2026 | 4.86 EUR | -2.8% | 4.34 EUR | 4.55 EUR | 0.97 | 12.15 | 114.6K | On |
| 15 May 2026 | 5.00 EUR | 0.0% | 4.31 EUR | 4.54 EUR | 0.96 | 18.05 | 94.5K | On |
| 8 May 2026 | 5.00 EUR | 6.8% | 4.27 EUR | 4.54 EUR | 0.85 | 16.18 | 11.4K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.